0       0

2020 Webinars


dri3525 - The FDA and CBD-Infused Products: Understanding the Rules of the Road


Jan 22, 2020 12:00pm ‐ Jan 22, 2020 1:00pm

Description

Since the legalization of hemp, we have seen explosive growth in hemp production, specifically the production of hemp-derived CBD products (e.g., food, beverages, topicals, dietary supplements, cosmetics and much more). However, the U.S. Food and Drug Administration (FDA), the Federal Trade Commission (FTC), states and localities, and plaintiff’s attorneys have not been shy about going after products in this space. In this exciting and interactive session, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current CBD regulatory and litigation landscape and how they might change.

Who Should Attend

  • Retailers/wholesalers
  • Product Developers
  • Distributors
  • Litigators
  • Regulators

What You Will Learn

  • How FDA, FTC, and other federal and state government agencies are regulating hemp/hemp-derived CBD products
  • The FDA’s approach to CBD and understanding what action, if any, that the FDA may take near term and long term
  • The importance of CBD sourcing, labeling, and testing

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content